Skip to main content
Premium Trial:

Request an Annual Quote

Labcorp to Acquire Myriad Genetics' Vectra Rheumatoid Arthritis Test for $150M

NEW YORK – Myriad Genetics has entered a definitive agreement to sell certain operating assets and intellectual property, including its Vectra rheumatoid arthritis test, to Labcorp for $150 million in cash.

The companies said that the deal for Vectra, a blood-based proteomic test that measures levels of 12 proteins to gauge disease activity in rheumatoid arthritis to monitor disease severity and treatment effectiveness, is expected to close in the third quarter of 2021.

Myriad acquired the Vectra test in 2014 through its $270 million purchase of Crescendo Bioscience, which developed the test. However, the company noted earlier this year that it was looking for someone to acquire the asset. According to Myriad, it has been used by more than 1 million patients and has been ordered by the majority of US rheumatologists.

"Our agreement with Labcorp meets our goals of ensuring broad access to the Vectra test for patients, ensuring a good home for our teammates, and delivering strong value for our shareholders," Paul Diaz, president and CEO of Myriad, said in a statement. "While we are strong believers in the future growth prospects for Vectra, this divestiture will allow us to increase operational focus and better execute in our core strategic businesses of women’s health, oncology, and mental health."

"Labcorp has consistently been a major player in rheumatology and continues to focus on providing medical professionals with the data they need to best treat their RA patients," said Brian Caveney, chief medical officer and president of Labcorp Diagnostics. "The addition of the Vectra testing capabilities to our in-house products offers tremendous potential for us to expand the test's availability and make Labcorp a single-source diagnostics solution for RA providers."

Last week, Castle Biosciences said it will acquire Myriad's myPath Melanoma laboratory and test for $32.5 million in cash and cash equivalents.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.